Pfizer
PFE
PFE
2,318 hedge funds and large institutions have $142B invested in Pfizer in 2019 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 986 increasing their positions, 1,010 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
19% less capital invested
Capital invested by funds: $176B → $142B (-$33.5B)
28% less first-time investments, than exits
New positions opened: 99 | Existing positions closed: 137
59% less funds holding in top 10
Funds holding in top 10: 199 → 81 (-118)
Holders
2,318
Holding in Top 10
81
Calls
$1.16B
Puts
$1.43B
Top Buyers
| 1 | +$1.44B | |
| 2 | +$462M | |
| 3 | +$228M | |
| 4 |
Sanders Capital
West Palm Beach,
Florida
|
+$174M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$161M |
Top Sellers
| 1 | -$1.22B | |
| 2 | -$713M | |
| 3 | -$362M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$351M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$329M |